Your browser doesn't support javascript.
loading
TFEB activation hallmarks antigenic experience of B lymphocytes and directs germinal center fate decisions.
Münchhalfen, Matthias; Görg, Richard; Haberl, Michael; Löber, Jens; Willenbrink, Jakob; Schwarzt, Laura; Höltermann, Charlotte; Ickes, Christian; Hammermann, Leonard; Kus, Jan; Chapuy, Björn; Ballabio, Andrea; Reichardt, Sybille D; Flügel, Alexander; Engels, Niklas; Wienands, Jürgen.
Afiliação
  • Münchhalfen M; Institute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
  • Görg R; Institute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
  • Haberl M; Institute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.
  • Löber J; Department of Medical Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Willenbrink J; Department of Hematology, Oncology, and Tumor Immunology, Charité, Campus Benjamin Franklin, University Medical Center Berlin, Berlin, Germany.
  • Schwarzt L; Institute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
  • Höltermann C; Institute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
  • Ickes C; Institute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
  • Hammermann L; Institute of Cardiovascular Physiology, University Medical Center Göttingen, Georg August University, Göttingen, Germany.
  • Kus J; Institute for Neuroimmunology and Multiple Sclerosis Research, University Medical Center Göttingen, Göttingen, Germany.
  • Chapuy B; Institute of Cellular & Molecular Immunology, University Medical Center Göttingen, Göttingen, Germany.
  • Ballabio A; Department of Medical Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.
  • Reichardt SD; Department of Hematology, Oncology, and Tumor Immunology, Charité, Campus Benjamin Franklin, University Medical Center Berlin, Berlin, Germany.
  • Flügel A; Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy.
  • Engels N; Department of Translational Medical Sciences, Federico II University, Naples, Italy.
  • Wienands J; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, USA.
Nat Commun ; 15(1): 6971, 2024 Aug 14.
Article em En | MEDLINE | ID: mdl-39138218
ABSTRACT
Ligation of the B cell antigen receptor (BCR) initiates humoral immunity. However, BCR signaling without appropriate co-stimulation commits B cells to death rather than to differentiation into immune effector cells. How BCR activation depletes potentially autoreactive B cells while simultaneously primes for receiving rescue and differentiation signals from cognate T lymphocytes remains unknown. Here, we use a mass spectrometry-based proteomic approach to identify cytosolic/nuclear shuttling elements and uncover transcription factor EB (TFEB) as a central BCR-controlled rheostat that drives activation-induced apoptosis, and concurrently promotes the reception of co-stimulatory rescue signals by supporting B cell migration and antigen presentation. CD40 co-stimulation prevents TFEB-driven cell death, while enhancing and prolonging TFEB's nuclear residency, which hallmarks antigenic experience also of memory B cells. In mice, TFEB shapes the transcriptional landscape of germinal center B cells. Within the germinal center, TFEB facilitates the dark zone entry of light-zone-residing centrocytes through regulation of chemokine receptors and, by balancing the expression of Bcl-2/BH3-only family members, integrates antigen-induced apoptosis with T cell-provided CD40 survival signals. Thus, TFEB reprograms antigen-primed germinal center B cells for cell fate decisions.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Receptores de Antígenos de Linfócitos B / Apoptose / Centro Germinativo / Antígenos CD40 / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos B / Receptores de Antígenos de Linfócitos B / Apoptose / Centro Germinativo / Antígenos CD40 / Fatores de Transcrição de Zíper de Leucina e Hélice-Alça-Hélix Básicos Limite: Animals Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Alemanha País de publicação: Reino Unido